Literature DB >> 7986555

Massive acute thrombosis of the descending thoracic aorta in heparin-associated thrombocytopenia and thrombosis.

D H Antecol1, V M Walley, K L Chan.   

Abstract

Heparin-associated thrombocytopenia with thrombosis is a rare but serious complication in patients receiving heparin therapy. We report a case of a patient with this complication who had massive thrombosis within the descending thoracic aorta detected by transesophageal echocardiography. Our case suggests that a transesophageal echocardiographic examination can be useful in the early diagnosis of heparin-associated thrombocytopenia and thrombosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986555     DOI: 10.1016/s0894-7317(14)80016-3

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  4 in total

Review 1.  Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia.

Authors:  J M Walenga; W P Jeske; H L Messmore
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

Review 2.  A critical reappraisal of the treatment modalities of normal appearing thoracic aorta mural thrombi.

Authors:  Georgios Karaolanis; Demetrios Moris; Chris Bakoyiannis; Diamantis I Tsilimigras; Viktoria-Varvara Palla; Eleftherios Spartalis; Dimitrios Schizas; Sotirios Georgopoulos
Journal:  Ann Transl Med       Date:  2017-08

3.  The usefulness of Duplex Doppler ultrasound in the angiological and dermatological diagnosis of patients with blue toe syndrome.

Authors:  Katarzyna Pawlaczyk; Marcin Gabriel; Daria A Strzelecka-Węklar; Zbigniew Krasiński; Michal Stanisic; Zofia Gabriel; Łukasz Dzieciuchowicz; Zygmunt Adamski
Journal:  Postepy Dermatol Alergol       Date:  2017-10-31       Impact factor: 1.837

4.  Blue Toe Syndrome: A Challenging Diagnosis.

Authors:  Federico Tartari; Ambra Di Altobrando; Yuri Merli; Annalisa Patrizi; Michele Mirelli; Tommaso Bianchi
Journal:  Indian J Dermatol       Date:  2019 Nov-Dec       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.